HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Google Scholar Articles by Wang, J. Articles by Higuchi, K. Articles citing this Article PubMed PubMed Citation Articles by Wang, J. Articles by Higuchi, K.

Wild Type ApoA-II Gene Does Not Rescue Senescence-Accelerated Mouse (SAMP1) From Short Life Span and Accelerated Mortality

^a Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, Canada
^b Field of Regeneration Control, Institute for Frontier Medical Science, Kyoto University, Kyoto, Japan
^c Department of Aging Angiology, Research Center on Aging and Adaptation, Shinshu University School of Medicine, Matsumoto, Japan
^d Atomic Bomb Disease Institute, Nagasaki University School of Medicine, Nagasaki, Japan

Keiichi Higuchi, Department of Aging Angiology, Research Center on Aging and Adaptation, Shinshu University School of Medicine, 3-1-1 Asahi, Matsumoto 390-8621, Japan E-mail: khiguchi{at}sch.md.shinshu-u.ac.jp.

Decision Editor: Jay Roberts, PhD

Biochemical and genetic data suggest that the Apoa2^c allele of the apolipoprotein A-II gene causes severe senile amyloidosis (AApoAII) in SAMP1, a mouse model for accelerated senescence. We analyzed the effects of replacement of Apoa2^c in SAMP1 mice with non-amyloidogenic Apoa2^b on amyloidosis, lipoprotein metabolism, and progression of senescence using a congenic strain, P1.R1-Apoa2^b, which has the Apoa2^b chromosome region of SAMR1 in the genome of SAMP1. Age-associated amyloid deposition was not observed, but plasma concentrations of apoA-II protein and HDL-cholesterol decreased with age in P1.R1-Apoa2^b. P1.R1-Apoa2^b showed lower scores of senescence than did SAMP1. However, the life span and mortality rate doubling time were similar in P1.R1-Apoa2^b and SAMP1. These results suggest that replacement of Apoa2^c with non-amyloidogenic Apoa2^b does not rescue SAMP1 mice from a short life span and accelerated mortality.